LUPIN.NS : Summary for LUPIN LTD INR2 - Yahoo Finance

U.S. Markets open in 6 hrs 44 mins

Lupin Limited (LUPIN.NS)


NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,489.00-1.25 (-0.08%)
As of 12:16PM IST. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1,490.25
Open1,494.90
Bid1,489.00 x
Ask1,489.35 x
Day's Range1,485.10 - 1,498.00
52 Week Range1,280.00 - 1,750.00
Volume167,436
Avg. Volume833,547
Market Cap672.58B
BetaN/A
PE Ratio (TTM)22.99
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bloomberg17 days ago

    Lupin CFO Says $1 Billion M&A War Chest May Be Just The Start

    Lupin Ltd.’s point man for mergers and acquisitions figures he has about $1 billion to work with as he hunts for targets to hasten the Indian firm’s move from simple generic drugs to more profitable products. ...

  • Business Wire4 months ago

    Lupin Receives FDA Approval for Generic Nuvigil® Tablets

    Pharma Major Lupin Limited announced today that its US subsidiary Lupin Pharmaceuticals, Inc. has received final approval for its Armodafinil Tablets 50 mg, 150 mg, 200 mg and 250 mg from the United States Food and Drug Administration to market a generic version of Cephalon, Inc.’s Nuvigil® Tablets 50 mg, 150 mg, 200 mg and 250 mg.

  • Bloomberg6 months ago

    Lupin Expects U.S. Approvals From Goa Factory in Two Months

    Lupin Ltd., India’s second-biggest drugmaker by market value, expects U.S. approvals for new products from its facility in the coastal state of Goa to begin again in the next two months as it addresses ...